PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19208803-4	2009	In this CML model, AS targets BCR/ABL through the ubiquitination of key lysine residues, leading to its proteasomal degradation, whereas IM inhibits the PI3K/AKT/mTOR pathway.	Lysine	72-78	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	30-37	
21781306-5	2011	Using mass spectrophotometry and site-specific acetyl antibody, we identified Abl K921, located in the DNA binding domain, and conforming to one of the lysine residue in the consensus acetylation motif (KXXK--X3-5--SGS) is acetylated following DNA damage.	Lysine	152-158	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	78-81	
22696202-0	2012	Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage.	Lysine	25-31	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	57-64	
22696202-6	2012	In this study we have investigated whether the expression of BCR-ABL could influence the acetylation of p53, specifically at lysine 317/320 (K317/K320), which has been shown to regulate nuclear export and transcription-independent apoptotic activity of p53.	Lysine	125-131	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	61-68	
22001646-6	2011	Intriguingly, nuclear-targeted c-Abl induces heterochromatic profiles of histone methylation and acetylation, including hypoacetylation of histone H4 acetylated on lysine 16 (H4K16Ac).	Lysine	164-170	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	31-36	
8757502-8	1996	32Dkit cells transfected with bcr/abl containing an inactivating point mutation (Lys-->Arg271) in the Abl kinase domain (32Dp210(Arg271)kit) retained their responsiveness to the effects of rhSF.	Lysine	81-84	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	30-37	
11160680-6	2001	This mutant encodes a v-Abl protein in which the beta B5 arginine at the base of the phosphotyrosine-binding pocket has been replaced by a lysine.	Lysine	139-145	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	22-27	
16648821-7	2006	Indeed, acetylation on Lys 730 drives c-Abl accumulation in the cytoplasm and promotes differentiation.	Lysine	23-26	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	38-43	
16648821-8	2006	Thus, Lys 730 acetylation is a novel post-translational modification of c-Abl and a novel mechanism for modulating its subcellular localization that contributes to myogenic differentiation.	Lysine	6-9	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	72-77	
16151465-1	2005	We have identified a gene polymorphism (K247R) within or close to the P-loop of BCR-ABL, which leads to the substitution of arginine for lysine.	Lysine	137-143	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	84-87	
8757502-8	1996	32Dkit cells transfected with bcr/abl containing an inactivating point mutation (Lys-->Arg271) in the Abl kinase domain (32Dp210(Arg271)kit) retained their responsiveness to the effects of rhSF.	Lysine	81-84	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	105-108	
31374292-4	2019	We found that histone H3 lysine 4 (H3K4) demethylase RBP2 expression is negatively correlated with BCR-ABL expression, which suggests a regulatory link between these two genes.	Lysine	25-31	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	99-106